TGFB1 and head and neck squamous cell carcinoma: HPV + HNSCC‐derived exosomal miR‐9‐5p inhibits TGF‐β mediated fibroblast activation through NOX4, which is correlated with a better prognosis of HPV + HNSCC patients [78].